Treatment of Acquired Hemophilia A (AHA) with Rituximab (R): Clinical Outcomes and Cost of Hemostatic Agents

被引：0
|
作者：
Roengvoraphoj, Monic [1 ]
Jensen, Eleanor R. [1 ]
Mckernan, Laurel [1 ]
Briggs, Anna [1 ]
Ornstein, Deborah L. [2 ,3 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
[2] Dartmouth Med Sch, Dept Pathol, Lebanon, NH USA
[3] Dartmouth Med Sch, Dept Med, Lebanon, NH USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1358 / 1358
页数：1
相关论文
共 50 条
  • [31] Successful treatment with low-dose rituximab and cyclosporine in acquired hemophilia A: a case report and review of the literature
    Hao, Shanfeng
    Xiao, Na
    Qu, Wen
    Fu, Rong
    Shao, Zonghong
    Zhang, Yang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 6270 - 6274
  • [32] EMICIZUMAB TREATMENT IN PATIENT WITH ACQUIRED HEMOPHILIA CAN BE A RELAY TO BYPASSING AGENTS: A CASE REPORT
    Toutain, I. Martin
    Launois, A.
    Lambert, J.
    Longval, T.
    Merabet, F.
    Jaidi, R.
    LeDore, S.
    Ferre, E.
    De Raucourt, E.
    Flaujac, C.
    HAEMOPHILIA, 2023, 29 : 98 - 98
  • [33] DIRECT COMPARISON OF PROPHYLAXIS COST IN PATIENTS WITH SEVERE HEMOPHILIA A WITH AND WITHOUT INHIBITORS WITH HEMOSTATIC AGENTS VERSUS THE USE OF EMICIZUNIAB IN GUATEMALA
    Leal Lopez, A. M.
    Oliva Lara, S. C.
    VALUE IN HEALTH, 2022, 25 (12) : S181 - S181
  • [34] THE EFFECTIVENESS AND COST OF HEMOSTATIC AGENTS IN PERIOPERATIVE OUTCOMES DURING ROBOTIC NEPHRON-SPARING PROCEDURES
    Pickhardt, Mark
    Sundaram, Chandru
    JOURNAL OF UROLOGY, 2020, 203 : E257 - E257
  • [35] Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases
    Hiroki Hosoi
    Yuina Akagi
    Toshiki Mushino
    Masahiro Takeyama
    Naoto Minoura
    Takayuki Hiroi
    Yoshiaki Furuya
    Masaya Morimoto
    Shogo Murata
    Shinobu Tamura
    Takashi Sonoki
    Thrombosis Journal, 20
  • [36] Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases
    Hosoi, Hiroki
    Akagi, Yuina
    Mushino, Toshiki
    Takeyama, Masahiro
    Minoura, Naoto
    Hiroi, Takayuki
    Furuya, Yoshiaki
    Morimoto, Masaya
    Murata, Shogo
    Tamura, Shinobu
    Sonoki, Takashi
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [37] Successful Treatment of Acquired Hemophilia A with Bortezomib Plus Low Dose Rituximab in a Patient with Renal Failure and Severe Pneumonia
    Zhou, Yin
    Zhang, Yan
    Zhuang, Zhe
    Zhang, Yanbin
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (01) : 171 - 172
  • [38] Successful Treatment of Acquired Hemophilia A with Bortezomib Plus Low Dose Rituximab in a Patient with Renal Failure and Severe Pneumonia
    Yin Zhou
    Yan Zhang
    Zhe Zhuang
    Yanbin Zhang
    Indian Journal of Hematology and Blood Transfusion, 2021, 37 : 171 - 172
  • [39] Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic Purpura
    Abou-Ismail, Mouhamed Yazan
    Arafah, Yasmin
    Fu, Pingfu
    Cao, Shufen
    Schmaier, Alvin H.
    Nayak, Lalitha V.
    BLOOD, 2019, 134
  • [40] The Clinical Associations and Outcomes of Patients Admitted with Acquired Hemophilia; A Review of the 2012 National Inpatient Sample
    Shatzel, Joseph
    Azar, Sharl
    Gay, Nathanael David
    Luo, Jai
    Deloughery, Thomas G.
    Recht, Michael
    Taylor, Jason A.
    BLOOD, 2015, 126 (23)
12345